Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

The above mentioned studies and data represent the latest results of clinical research for each treatment and are not necessarily part of the indicated licence in each country. For detailed label information, visit the website of your health authority or the EMEA website http://www.emea.europa.eu/

Note to Editors

Breast cancer is the most common cancer among women worldwide.(i) Each year more than one million new cases of breast cancer are diagnosed worldwide, and nearly 400,000 people will die of the disease annually. (ii) In HER2- positive breast cancer, increased quantities of the HER2 protein are present on the surface of the tumour cells. This is known as 'HER2-positivity'. High levels of HER2 are present in a particularly aggressive form of the disease which responds poorly to chemotherapy. Research shows that HER2-positivity affects approximately 20-30 percent of women with breast cancer.(iii)

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the

central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

10

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the ... detection of pathogenic bacteria, including potential bioterrorism agents ... Bacillus anthracis which feature on the Center ... bio-threats. This seminal study, conducted in collaboration with ... Salisbury (DSTL), United Kingdom ...
(Date:5/20/2013)... YORK , May 20, 2013  Echo Pharma ... 2.5 of the Irish Takeover Rules (the "Announcement"), a ... plc (NYSE: ELN ) to $12.50 per ... cash confirmed and not conditional on due diligence.  The ... Royalty Pharma has reserved the right to waive down ...
(Date:5/20/2013)... Mai 2013 Sequent Medical, Inc. ... CE-Kennzeichnung für die SL-Produktfamilie („Single Layer") seiner ... hat. Das Unternehmen hat in ausgewählten neurovaskulären ... Einführung dieser neuen Modelle begonnen. Neben einem ... verbessertes Handling, das es Ärzten ermöglicht, ein ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3
... Dec. 16, 2010 Watson Pharmaceuticals, Inc. (NYSE: ... today announced that Watson,s subsidiary, Watson Laboratories, Inc. has ... ("Preglem") the wholly owned subsidiary of Richter, to develop ... Canada.  In European studies, Esmya™ has been shown to ...
... announced today the award recipients from its November Virtual ... March of Dimes, National Prematurity Awareness Month. This year ... Neonatal Intensive Care Unit. In addition, the number of ... six in 2010.  Each of the following hospitals will ...
Cached Medicine Technology:Watson and Richter Announce Exclusive License Agreement for Esmya™ 2Watson and Richter Announce Exclusive License Agreement for Esmya™ 3Watson and Richter Announce Exclusive License Agreement for Esmya™ 4Watson and Richter Announce Exclusive License Agreement for Esmya™ 5Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2010 Prematurity Awareness Month 2
(Date:5/20/2013)... May 20, 2013 Fastcare Miami Beach ... infection (UTI) within its first symptoms, as if not treated, ... a more serious infection. Although a urinary tract infection in ... lead to serious kidney infection called pyelonephritis. Women seem to ... come up to the same percentage as women after the ...
(Date:5/20/2013)... May 20, 2013 In order to prepare ... and wellness team from DrSmartphoneMD launched an article series to ... , The series launched with the precautions that ... of the DrSmartphoneMD program are not one of the 3.5 ... that more than 90% of all skin cancer cases are ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... been released to the public creating a frenzy ... access to this elite business training. WealthSpringMarketing.com's Tiffany ... as well as an exclusive bonus. , "Eben ... providing elite business training to individuals serious about ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Parker Waichman ... rights of victims injured by defective drugs, has filed ... who alleges that use of the diabetes drug medication ... was filed on April 30, 2013, in the U.S. ... No. 6:13-cv-0888), where it is one of thousands of ...
(Date:5/20/2013)... Leading facial plastic surgeon and ENT specialist Dr. ... Doc” in the field of Otolaryngology in the May/June 2013 ... Beacher magazine, one of Palm Beach County’s leading lifestyle publications, ... 2013 issue, including 70 of the very best physicians in ... to do, health and fitness, people to watch, top doctors, ...
Breaking Medicine News(10 mins):Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Combat Skin Cancer In Summer Months 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
... meditation training are associated with greater telomerase activity, according ... the University of California, San Francisco. The study is ... an enzyme important for the long-term health of cells ... attributable to psychological changes that increase a person,s ability ...
... Nov. 3 Stereotactic body radiotherapy (SBRT), a radiation ... Institute (UPCI) that precisely delivers a large dose of ... and neck cancers when combined with the chemotherapy Cetuximab, ... research will be presented today at the American Society ...
... suggests that older adults who wear multifocal contact lenses ... condition that increases with age, may have greater difficulty ... Age-related problems with near vision, medically termed presbyopia, usually ... the inability to focus on objects up close. ...
... HealthDay Reporter , WEDNESDAY, Nov. 3 (HealthDay News) -- ... between asthma and lung cancer in a small study. ... pulmonary disease (COPD) and lung cancer, but this is the ... and lung cancer, the researchers said. However, based on ...
... professionals, has been selected to serve as a partner ... beginning Sept. 21, 2010. A coalition of 48 ... reconstitute the NPP, which currently comprises 32 organizations working ... The NPP,s previous work has targeted ways to eliminate ...
... Calif., Nov. 3, 2010 The U.S. Department of Veterans ... scientist the highest honor it bestows on scientists. ... Department of Orthopaedic Surgery, will receive $1.4 million to support ... Beach VA Medical Center. "Dr. Lee is one of ...
Cached Medicine News:Health News:Positive psychological changes from meditation training linked to cellular health 2Health News:Positive psychological changes from meditation training linked to cellular health 3Health News:Combining radiation therapy, chemotherapy safely treats head and neck cancer patients 2Health News:Multifocal contact lenses may reduce vision for night driving 2Health News: Asthma Linked to Lung Cancer Risk in Study 2Health News:National Quality Forum picks AMIA for national priorities partnership 2Health News:VA names UCI orthopedic biomedical engineer a senior research career scientist 2
TC-98 elisa strip reader. Reads, calculates, and prints results for up to 12 wells in about 30 seconds. Single point calibration. Multi-point calibration....
... Personal Plate Shaker with Timer are designed ... of 96 & 384-well microplates. The on/off button, ... located on the side of the unit. The ... the unit for adjustment of speed from a ...
The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
... flow cytometer for all applications in Cytomics ... absolute counting. The CyFlow ML allows to ... signals in combination with up to 13 ... can perform in a wide variety of ...
Medicine Products: